Company intelligence / Profile preview

DEEP Measures

Helsinki, Finland

Ownership: Private
Development stage: Other

Overview

DEEP Measures has launched a commercial platform that structures and accelerates the creation of regulatory-accepted digital clinical trial endpoints, supporting programs with partners in disease areas such as dermatology, neurology, respiratory, and cardiology. The company runs both its own and collaborative missions for development and validation of digital measurement tools, with early access and partner programs in progress.

Therapeutic areas: CardiovascularPulmonologyNeurologyOtherDermatology
Modalities: DeviceDigital measureWearableBiosensor
Industry: Digital Health Medical Devices

Partnerships

Vitaccess (partner for Myasthenia Gravis program)Pharmaceutical companies (not explicitly named)Technology providersHealth authorities (e.g., EMA)

Beyond the preview

Go deeper on DEEP Measures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DEEP Measures.

Explore the full profile